Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,917 | -50,601 | -37,923 | -25,866 | -12,958 |
| Depreciation Amortization | 1,387 | 4,393 | 3,077 | 1,995 | 1,008 |
| Accounts receivable | 1,558 | -2,250 | 1,719 | 1,406 | 1,385 |
| Accounts payable and accrued liabilities | -2,821 | 4,105 | 916 | 1,289 | 617 |
| Other Working Capital | -6,084 | 1,052 | 2,755 | 3,702 | 3,450 |
| Other Operating Activity | 4,312 | 7,664 | 4,297 | 1,979 | 455 |
| Operating Cash Flow | $-15,565 | $-35,637 | $-25,159 | $-15,495 | $-6,043 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,596 | -15,623 | -24,836 | 2,118 | 0 |
| PPE Investments | -1,888 | -7,000 | -5,105 | -2,404 | -966 |
| Purchase Sale Intangibles | N/A | -1,500 | -800 | -800 | -800 |
| Other Investing Activity | 0 | -1,500 | -800 | -800 | -800 |
| Investing Cash Flow | $12,708 | $-24,123 | $-30,741 | $-1,086 | $-1,766 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | 10,000 | 10,000 | N/A |
| Debt Repayment | -6 | -40 | -28 | -17 | -5 |
| Common Stock Issued | 88 | 31,632 | 30,955 | 801 | 345 |
| Other Financing Activity | -20 | -1,233 | -1,121 | -30 | -10 |
| Financing Cash Flow | $62 | $40,359 | $39,806 | $10,754 | $330 |
| Exchange Rate Effect | 14 | -25 | 2 | 3 | 7 |
| Beginning Cash Position | 16,717 | 36,143 | 35,385 | 35,385 | 35,385 |
| End Cash Position | 13,936 | 16,717 | 19,293 | 29,561 | 27,913 |
| Net Cash Flow | $-2,781 | $-19,426 | $-16,092 | $-5,824 | $-7,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,565 | -35,637 | -25,159 | -15,495 | -6,043 |
| Capital Expenditure | -1,888 | -7,000 | -5,105 | -2,404 | -966 |
| Free Cash Flow | -17,453 | -42,637 | -30,264 | -17,899 | -7,009 |